c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification

c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification [RNA-seq]

Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance (zfChIPseq)

Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance (zfRNAseq)

Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance

Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance [zf3primeseq]

Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State

Cell-Type-Specific TGF-beta Signaling is Targeted to Genes that Control Cell Identity: ChIP-Seq

Cell-Type-Specific TGF-beta Signaling is Targeted to Genes that Control Cell Identity

ChIP-Seq of Oct4 in Human Embryonic stem cells.

ChIP-Seq of Histone Methylation and RNAP2 in Human Jurkat cells.

H3K27me3, H3K79me2, and Suz12 ChIP-Seq in Human Embryonic Stem Cells (BG03).

Transcription factor ChIP-seq in expanded human hematopoietic stem and progenitor cells

Chromatin marks and RNA Pol II in human hematopoietic stem and progenitor cells

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

Identification of differentially expressed genes upon shRNA knockdown of TAL1 and its regulatory partners in T-ALL cells (Jurkat)

ChIP-Seq of TAL1 and its regulatory partners in T-ALL cells

Core transcriptional regulatory circuit controlled by the TAL1 complex in human T-cell acute lymphoblastic leukemia

Core transcriptional regulatory circuit controlled by the tal1 complex in human t-cell acute lymphoblastic leukemia (Subseries)

Transcriptional Amplification in Tumor Cells with Elevated c-Myc